Keyphrases
Tuberous Sclerosis Complex
100%
Microglia
50%
Transcriptional Profiling
50%
Major Depressive Disorder
50%
Gray Matter Volume
50%
MicroRNA-34a (miR-34a)
50%
Early Brain Development
50%
Corticogenesis
50%
Cell Adhesion Molecules
50%
Early Postnatal Period
50%
Cortical Tuber
32%
Gray Matter
25%
Mammalian Target of Rapamycin (mTOR)
19%
Tuber
15%
Gene Expression
15%
Control Tissue
13%
Overexpression
11%
Low Expression
10%
Quantitative PCR
10%
Complex Patients
10%
Protein Expression
10%
CD163
10%
Immunohistochemical Staining
10%
Age-matched
10%
Transcriptome Analysis
10%
White Matter
10%
Cortex
8%
Genetic Disease
8%
Autopsy
8%
Dysregulation
8%
Western Blot
5%
Gene Expression Changes
5%
Adult Brain
5%
CD200
5%
Brain Tissue
5%
Effector Mechanisms
5%
Fetal Development
5%
Autism Spectrum Disorder
5%
Structural Brain Abnormalities
5%
Synaptosomes
5%
Corpus Callosum
5%
In Situ Hybridization
5%
Tissue Analysis
5%
Western Blot Analysis
5%
Cortical Tissue
5%
Gene Expression Profile
5%
Comorbidity
5%
Neuroblastoma Cells
5%
Phagocytosis
5%
Model in Vitro
5%
Neuroscience
Tuberous Sclerosis
100%
Brain Development
55%
Major Depressive Disorder
50%
microRNA 34a
50%
Corticogenesis
50%
Gray Matter
50%
Microglia
50%
Cell Adhesion Proteins
50%
Mammalian Target of Rapamycin Complex 1
25%
Gene Expression
24%
Western Blot
14%
Immunohistochemistry
14%
Transfection
10%
Neuroblastoma
10%
Astrocyte
10%
In Vitro
10%
Comorbidity
10%
Protein Expression
10%
Real-Time Polymerase Chain Reaction
9%
Staining Technique
9%
Cell Line
5%
Cell Adhesion
5%
Epileptic Seizure
5%
Brain Abnormalities
5%
Pervasive Developmental Disorder
5%
In Situ Hybridization
5%
Transcriptomics
5%
